바이오인

Mindful of the need to capitalise on emerging innovations, and conscious of the scientifi c and commercial potential of synthetic biology, EASAC assembled a working group of independent experts on the topic. Drawn from across the EU and chaired by the Council’s president Volker ter Meulen, it compiled a report titled Realising European Potential in Synthetic Biology: Scientifi c Opportunities and Good Governance. Drawing in part on previous work published by individual member academies, the report reviews the current state of synthetic biology, and suggests why and how the countries of the EU could and should contribute to its further development. It is available on the EASAC website.